AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06439355 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor assessment
Description: MDS-UPDRS scale PART III
Study NCT06439355 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neurocognitive assessment
Description: MoCA and MMSE scales
Study NCT06439355 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurocognitive assessment
Description: MoCA and MMSE scales
Study NCT06439355 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nutritional assessment
Description: anthropometric data (weight, height, BMI, waist circumference, hip circumference, android/gynoid ratio, triceps skin fold, brachial circumference), bioelectrical impedancemetry (fat mass, lean mass, water mass and bone mass)
Study NCT06439355 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nutritional assessment
Description: anthropometric data (weight, height, BMI, waist circumference, hip circumference, android/gynoid ratio, triceps skin fold, brachial circumference), bioelectrical impedancemetry (fat mass, lean mass, water mass and bone mass)
Study NCT06544317 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physical training
Description: All children received a series of 90-minute sessions 3 times a week for 8 weeks of after-school physical training. Each session began with a warm-up (20 min), three or four tasks related to the skill to be developed (aerobic training, resistance training, other activities designed to improve motor skills and balance, stretching and flexibility activities and core strength and posture exercises; 60 min) and a cool-down (10 min). Children were divided into six groups, with the number of children in each group ranging from eight to twelve.
Study NCT04987034 — intervention group
Intervention type: DEVICE
Intervention: EchoTip® Insight™
Description: Patients will undergo procedure where HVPG is obtained under mild sedation, next the patients will undergo anesthesia and mechanical intubation where HVPG measurements will be obtained simultaneously with the EchoTip Insight measurement. For patients receiving a transjugular intrahepatic portosystemic shunt (TIPS), direct portal vein pressure measurements will be obtained by the EchoTip® Insight™ and compared to the transjugular direct portal vein measurement obtained during the interventional radiology (IR) procedure.
Study NCT05302271 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AAVrh.10hFXN, serotype rh.10 adeno-associated virus (AAV) gene transfer vector expressing the cDNA coding for human FXN
Description: AAVrh.10hFXN will be administered intravenously.
Study NCT06544317 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: physical training
Description: All children received a series of 90-minute sessions 3 times a week for 8 weeks of after-school physical training. Each session began with a warm-up (20 min), three or four tasks related to the skill to be developed (aerobic training, resistance training, other activities designed to improve motor skills and balance, stretching and flexibility activities and core strength and posture exercises; 60 min) and a cool-down (10 min). Children were divided into six groups, with the number of children in each group ranging from eight to twelve.
Study NCT04342923 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Blood analysis
Study NCT06541158 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive usual care
Study NCT06541158 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Discussion
Description: Participate in a CAB
Study NCT06541158 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Educational Intervention
Description: Receive PAF pamphlet
Study NCT06541158 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Promotion and Care
Description: Receive the TRACT program
Study NCT06541158 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Media Intervention
Description: Receive transportation awareness brief video
Study NCT06541158 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06541158 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06424171 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac and brain magnetic resonance imaging.
Description: Cardiac magnetic resonance imaging with analysis using 4D flow. Brain magnetic resonance imaging to detect strokes, including microvascular strokes.
Study NCT05566704 — intervention group
Intervention type: DEVICE
Intervention: Modulus ALIF System
Description: The Modulus ALIF System is designed to address lumbar pathologies utilizing interbody placement through an anterior or anterolateral surgical approach. The Modulus ALIF System is an interfixated interbody system available in various shapes and sizes to suit the individual pathology and anatomical conditions of the patient.
Study NCT05838443 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Self-directed mindfulness utilizing a multi-sensor EEG-supported device with neurofeedback-assisted and technology-supported meditation
Description: Neurofeedback-assisted, technology-supported mindfulness via EEG-supported device delivered individually without the need for a facilitator or travel to training site. The device allows noninvasive neural activity recording from frontal and posterior brain regions. A dedicated smartphone application uses the EEG data to provide real-time adaptive feedback-modulating natural sounds to prompt user awareness of mind-wandering and intentional return to present experience. A smartphone app will guide patients through attention and focus on breath exercises. Patients will hear their distracted mind as the wind. Wind becomes stronger if their mind wanders, prompting patient's awareness of their wandering mind and guiding the patient back to focusing on their breath without judgment of how they are doing. Patients will be asked to practice mindfulness using the device for 20 minutes per day for 4 sessions prior to surgery.
Study NCT05838443 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Provider-directed mindfulness
Description: Patients will receive mental health support by a licensed social work provider who is trained in mindfulness through four 20-minute telehealth sessions. Patients will be taught cognitive behavioral therapy (CBT) techniques to reduce pain catastrophizing and increase coping efficacy, the clinician will review patient's current sleep routine and teach concepts and strategies to improve sleep. Patients will be guided through mindfulness and meditation exercises to improve pain and mood coping. Mindfulness-based instructions takes patients through quieting their mind by focusing on breath, expanding focus (i.e., at the tip of their nose full flow of the breath), with emphasis on acknowledgement of arising thoughts/emotions without judgement or emotional reaction, and return attention back to breath sensation. Principles of CBT and mindfulness will be reiterated at subsequent sessions.
Study NCT05838443 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Conventional Care
Description: Control group, as defined by our institution's standard preoperative care for given procedure, which does not include psychological preparation.
Study NCT05105542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
Description: The radiotracer, \[11C\]EMO, will be administered at the beginning of each PET scan.
Study NCT05105542 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PET Scan
Description: PET scanner with high sensitivity and resolution available for human brain imaging
Study NCT06439355 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Taste tests
Description: Recording of PEGs in response to a sucrose solution and a free fatty acid solution (prepared beforehand)
Study NCT06439355 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Taste tests
Description: Recording of PEGs in response to a sucrose solution and a free fatty acid solution (prepared beforehand)
Study NCT05655754 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methohexital
Description: anesthesia during ECT
Study NCT05655754 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketofol
Description: anesthesia during ECT
Study NCT05473923 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Receiving chemotherapeutic or targeted drugs recommended by molecular tumor board.
Description: Patients will be treated with FDA-approved chemotherapeutic or targeted drugs which were recommended by the molecular tumor board (MTB), based on their expertise, patients willingness as well as evidences from PTCs-drug screening and bioinformatic prediction for drug response.
Study NCT06198023 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Educational
Description: The educational intervention is an 8-session series of informational presentations about brain function and altered social processing related to eating disorders. Participants will receive a reflective prompt to complete as homework and will have an opportunity to discuss their responses during the following session.
Study NCT06198023 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interactive
Description: The interactive intervention is an 8-session series of experiential art therapy tasks followed by education about social processing. Participants will complete the tasks as a group or in small teams. Afterward, they will be encouraged to discuss their thoughts and feelings related to their experience. The educational component will include a homework assignment that participants will have the opportunity to discuss at the following session.
Study NCT05398302 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Image Guided Biopsy
Description: Undergo image-guided biopsy
Study NCT05032001 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Biguanide, DPP4 inhibitors, SGLT2 inhibitors
Description: Oral antidiabetic treatment during twelve weeks
Study NCT05905523 — intervention group
Intervention type: OTHER
Intervention: Assessing prewriting skills in children
Description: In this study, your child will be asked to do the following things:~1. Play a drawing game on a tablet~2. Copy shapes using a pencil in a paper booklet~3. Write some letters and cut paper with scissors You will complete surveys and answer questions about your child's development
Study NCT05819086 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rate Emotional Response
Description: Participants will view their assigned video package, and will be asked to rate their emotional response to the message
Study NCT05819086 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Rate Emotional Response
Description: Participants will view their assigned video package, and will be asked to rate their emotional response to the message
Study NCT05819086 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rate Impact of Message
Description: Participants will view their assigned video package, and will be asked to rate the impact of the presented messages on motivation to quit smoking.
Study NCT05819086 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Rate Impact of Message
Description: Participants will view their assigned video package, and will be asked to rate the impact of the presented messages on motivation to quit smoking.
Study NCT04839523 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exufiber
Description: A sterile nonwoven wound dressing made from highly absorbent PVA fibers.
Study NCT04839523 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exufiber Ag+
Description: A sterile nonwoven wound dressing made from highly absorbent PVA fibers, and coated with silver sulphate.
Study NCT05857930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OM-85
Description: OM-85 capsule (3.5mg) contents will be mixed with adequate quantity of water, fruit juice or milk/formula and orally administered once a day for 6 consecutive months.
Study NCT05857930 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsule contents will be mixed with adequate quantity of water, fruit juice or milk/formula and orally administered once a day for 6 consecutive months.
Study NCT06097676 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT06097676 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alprazolam 2 mg
Description: Oral dose of alprazolam 2 mg
Study NCT06097676 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin Enacarbil Immediate Release (GE-IR) 200 mg
Description: Oral dose of GE-IR 200 mg
Study NCT06097676 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin Enacarbil Immediate Release (GE-IR) 450 mg
Description: Oral dose of GE-IR 450 mg
Study NCT06097676 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin Enacarbil Immediate Release (GE-IR) 700 mg
Description: Oral dose of GE-IR 700 mg
Study NCT05302271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone
Description: All participants will remain immunosuppression therapy with prednisone for a total of 14 weeks.
Study NCT04685616 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Involved site radiotherapy
Description: Involved site radiotherapy as per International Lymphoma Radiation Oncology Group (ILROG) guidelines.~Recommended dose 30Gy
Study NCT04685616 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Involved site radiotherapy
Description: Involved site radiotherapy as per International Lymphoma Radiation Oncology Group (ILROG) guidelines.~Recommended dose 30Gy
Study NCT04685616 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Description: See arm description
Study NCT05254548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ACT-539313
Description: 100 mg ACT-539313 (hard capsules) will be administered twice per day in period 2 (morning and evening of Day 8), period 3 (morning and evening of Day 9 to 14) and period 4 (morning and evening of Day 15).
Study NCT05254548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Flurbiprofen
Description: One daily dose of flurbiprofen 50 mg will be administered in period 1 (morning of Day 1), period 2 (morning of Day 8), and period 4 (morning of Day 15).
Study NCT05254548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omeprazole
Description: A single dose of omeprazole 20 mg will be administered in period 1 (morning of Day 1), period 2 (morning of Day 8), and period 4 (morning of Day 15).
Study NCT05254548 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: A single dose of midazolam 2 mg will be administered in period 1 (morning of Day 1), period 2 (morning of Day 8), and period 4 (morning of Day 15).
Study NCT05508503 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Test of methylated NTMT1 and MAP3K14-AS1
Description: A dual-target test kit to detect methylated NTMT1 and MAP3K14-AS1 in blood samples.
Study NCT05508503 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FIT
Description: Fecal immunochemical test（optional）
Study NCT04685616 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Doxorubicin
Description: See arm description
Study NCT04685616 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bleomycin
Description: See arm description
Study NCT05417555 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Low-Intensity Focused Ultrasound Pulsation (LIFUP)
Description: Low intensity focused ultrasound pulsation will be administered to the left entorhinal cortex at 650kHz, ispta.3 720mW/cm, pulse repetition frequency 100Hz, duty cycle 50%, duration 30s with 30s spacing between sonications, 6 sonications per dose (participants receive 0, 1, 2 or 3 doses depending on group assignment)
Study NCT04685616 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brentuximab vedotin
Description: See arm description
Study NCT04685616 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vinblastine
Description: See arm description
Study NCT04685616 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vinblastine
Description: See arm description
Study NCT04685616 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dacarbazine
Description: See arm description
Study NCT04685616 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dacarbazine
Description: See arm description
Study NCT04685616 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Haematopoietic growth factor
Description: See arm description
Study NCT05704348 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy with gastropexy
Description: Gastropexy in this project means suturing the gastric remnant to the gastrocolic ligament.
Study NCT06546410 — intervention group
Intervention type: DEVICE
Intervention: BioEP
Description: All patient's EEG will have the BioEP score conducted on it
Study NCT05704348 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sleeve gastrectomy without gastropexy
Description: Sleeve gastrectomy without suturing the gastric remnant to the gastrocolic ligament.
Study NCT06346314 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular retraction exercise
Description: Participant lies prone with hands superior to the head on a treatment plinth and lifts their elbows 10 repetitions for three sets with 30 seconds of rest between each set.
Study NCT05417555 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Low-Intensity Focused Ultrasound Pulsation (LIFUP)
Description: Low intensity focused ultrasound pulsation will be administered to the left entorhinal cortex at 650kHz, ispta.3 720mW/cm, pulse repetition frequency 100Hz, duty cycle 50%, duration 30s with 30s spacing between sonications, 6 sonications per dose (participants receive 0, 1, 2 or 3 doses depending on group assignment)
Study NCT05381259 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: hortitherapy in people living with Alzheimer's taking place in three different day care
Description: 6 users benefiting from the horticultural workshop and 6 others from a usual workshop (control group) This control group will benefit from its usual workshop while the other group will participate in the horticultural workshop.~If it is impossible to carry out the workshops outdoors (rain or high heat), the day reception centers will provide a room to allow the workshops to be carried out. They will be adapted in terms of activities and materials.
Study NCT04734990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Given IV or SC
Study NCT04734990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Seclidemstat
Description: Given PO
Study NCT05200182 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Neurofeedback with functional near infra-red spectroscopy
Description: the neurofeedback protocol will last 15 minutes per session, and during each session, the volunteer will have to increase the brain activity of his/her dorsolateral prefrontal cortex using a visual gauge representing the activity level of his/her own dorsolateral prefrontal cortex. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this activity level.
Study NCT05200182 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neurofeedback with functional near infra-red spectroscopy
Description: the neurofeedback protocol will last 15 minutes per session, and during each session, the volunteer will have to increase the brain activity of his/her dorsolateral prefrontal cortex using a visual gauge representing the activity level of his/her own dorsolateral prefrontal cortex. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this activity level.
Study NCT05200182 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Neurofeedback
Description: the participants will receive the same instruction but will be shown a random signal
Study NCT05200182 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: oral microbiota collection
Description: an examination and oral swab for oral microbiota analysis will be performed by a dentist
Study NCT05200182 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: oral microbiota collection
Description: an examination and oral swab for oral microbiota analysis will be performed by a dentist
Study NCT05200182 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Questionnaires
Description: questionnaires for pre-intervention behavioral characterization
Study NCT05200182 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaires
Description: questionnaires for pre-intervention behavioral characterization
Study NCT04536090 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isoquercetin (IQC-950AN)
Description: Isoquercetin will be administered by mouth twice daily for 28 days
Study NCT05200182 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: resting-state fMRI
Description: characterize the brain function of volunteers by resting-state fMRI
Study NCT05200182 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: resting-state fMRI
Description: characterize the brain function of volunteers by resting-state fMRI
Study NCT05200182 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: resting-state fMRI
Description: characterize the brain function of volunteers by resting-state fMRI